Home Life Sciences St. John's wort (Hypericum perforatum) counteracts cytokine-induced tryptophan catabolism in vitro
Article
Licensed
Unlicensed Requires Authentication

St. John's wort (Hypericum perforatum) counteracts cytokine-induced tryptophan catabolism in vitro

  • Christiana Winkler , Barbara Wirleitner , Katharina Schroecksnadel , Harald Schennach and Dietmar Fuchs
Published/Copyright: June 1, 2005
Biological Chemistry
From the journal Volume 385 Issue 12

Abstract

St. John's wort (Hypericum perforatum) is an ancient folk remedy that has antiviral and antibacterial properties. Anti-inflammatory effects of the plant have been described and the application of H. perforatum extract as an effective antidepressant is well established. In this study we assayed the effect of H. perforatum extract on cytokine-induced tryptophan degradation in human peripheral blood mononuclear cells. Simultaneously, changes in the production of the immune activation marker neopterin were monitored. Both these biochemical pathways are triggered by interferon-γ. Our results show that extracts of H. perforatum strongly down-regulate mitogen-mediated tryptophan degradation in a dose-dependent manner. This effect seems to be based on a suppressive activity of H. perforatum on activated immunocompetent cells, resulting in a diminished production of interferon-γ. In line with this finding, neopterin synthesis was strongly down-regulated by the plant extract. Our results suggest that the reduction of tryptophan degradation by H. perforatum might be important in the action of the plant as an antidepressant.

:

Corresponding author

References

Bennett, D.A., Phun, L., Polk, J.F., Voglino, S.A., Zlotnik, V., and Raffa, R.B. (1998). Neuropharmacology of St. John's wort (Hypericum). Ann. Pharmacother.32, 1201–1208.Search in Google Scholar

Buchholzer, M.-L., Dvorak, C., Chatterjee, S.S., and Klein, J. (2002). Dual modulation of striatal acetylcholine release by hyperforin, a constituent of St. John's wort. J. Pharmacol. Exp. Ther.301, 714–719.10.1124/jpet.301.2.714Search in Google Scholar

Butterweck, V. (2003). Mechanism of action of St John's wort in depression: what is known?CNS Drugs17, 539–562.10.2165/00023210-200317080-00001Search in Google Scholar

Capuron, L., Ravaud, A., Neveu, P.J., Miller, A.H., Maes, M., and Dantzer, R. (2002). Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol. Psychiatry7, 468–473.10.1038/sj.mp.4000995Search in Google Scholar

Cervo, L., Rozio, M., Ekalle-Soppo, C.B., Guiso, G., Morazzoni, P., and Caccia, S. (2002). Role of hyperforin in the antidepressant-like activity of Hypericum perforatum extracts. Psychopharmacology164, 423–428.10.1007/s00213-002-1229-5Search in Google Scholar

Chatterjee, S.S., Bhattacharya, S.K., Wonnemann, M., Singer, A., and Muller, W.E. (1998). Hyperforin as a possible antidepressant component of Hypericum extracts. Life Sci.63, 499–510.10.1016/S0024-3205(98)00299-9Search in Google Scholar

Fuchs, D., Werner, E.R., Dierich, M.P., and Wachter, H. (1988). Cellular immune activation in the brain and human immunodeficiency virus infection. Ann. Neurol.24, 289.10.1002/ana.410240227Search in Google Scholar PubMed

Fuchs, D., Weiss, G., and Wachter, H. (1993). Neopterin, biochemistry and clinical use as a marker for cellular immune reactions. Int. Arch. Allergy Immunol.101, 1–6.10.1159/000236491Search in Google Scholar PubMed

Greeson, J.M., Sanford, B., and Monti, D.A. (2001). St. John's wort (Hypericum perforatum): a review of the current pharmacological, toxicological, and critical literature. Psychopharmacology153, 402–414.Search in Google Scholar

Heyes, M.P., Saito, K., Crowley, J.S., Davis, L.E., Demitrack, M.A., Der, M., Dilling, L.A., Elia, J., Kruesi, M.J., and Lackner, A. (1992). Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain115, 1249–1273.10.1093/brain/115.5.1249Search in Google Scholar PubMed

Hostanka, K., Reichling, J., Bommer, S., Weber, M., and Saller, R. (2002). Aqueous ethanolic extract of St. John's wort (Hypericum perforatum L.) induces growth inhibition and apoptosis in human malignant cells in vitro. Pharmazie57, 323–331.Search in Google Scholar

Huang, A., Fuchs, D., Widner, B., Glover, C., Henderson, D.C., and Allen-Mersh, T.G. (2002). Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer. Brit. J. Cancer86, 1691–1696.10.1038/sj.bjc.6600336Search in Google Scholar PubMed PubMed Central

Huber, C., Batchelor, J.R., Fuchs, D., Hausen, A., Lang, A., Niederwieser, D., Reibnegger, G., Swetly, P., Troppmair, J., and Wachter, H. (1984). Immune response-associated production of neopterin – release from macrophages primarily under control of interferon-γ. J. Exp. Med.160, 310–316.10.1084/jem.160.1.310Search in Google Scholar PubMed PubMed Central

Jensen, A.G., Hansen, S.H., and Nielsen, E.Ø. (2001). Adhyperforin as a contributor to the effect of Hypericum perforatum L. in biochemical models of antidepressant activity. Life Sci.68, 1593–1605.Search in Google Scholar

Laakmann, G., Schüle, C., Baghai, T., and Kieser, M. (1998). St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy. Pharmacopsychiatry31, 54–59.Search in Google Scholar

Lavie, G., Valentine, F., Levin, B., Mazur, Y., Gallo, G., Lavie, D., Weiner, D., and Meruelo, D. (1989). Studies of the mechanisms of action of the antiretroviral agents hypericin and pseudohypericin. Proc. Natl. Acad. Sci. USA86, 5963–5967.10.1073/pnas.86.15.5963Search in Google Scholar

Linde, K., Ramirez, G., Mulrow, C.D., Pauls, A., Weidenhammer, W., and Melchart, D. (1996). St. John's wort for depression—an overview and meta-analysis of randomised clinical trials. Br. Med. J.313, 253–258.Search in Google Scholar

Lomagno, P., and Lomagno, R.C. (1979). Activity of Hypericum perforatum oil in the treatment of the bedsores in old people. Fitoterapia50, 201–205.Search in Google Scholar

Lyvie, G., Mazur, Y., Lavie, D., and Meruelo, D. (1995). The chemical and biological properties of hypericin: a compound with a broad spectrum of biological activities. Med. Res. Rev.15, 111–119.10.1002/med.2610150203Search in Google Scholar

Maes, M., Meltzer, H.Y., Scharpe, S., Bosmans, E., Suy, E., De Meester, I., Calabrese, J., and Cosyns, P. (1993). Relationships between lower plasma l-tryptophan level and immune–inflammatory variables in depression. Psychiatry Res.49, 151–165.10.1016/0165-1781(93)90102-MSearch in Google Scholar

Maisenbacher, P., and Kovar, K.A. (1992). Analysis and stability of Hyperici oleum. Planta Med.58, 351–354.10.1055/s-2006-961483Search in Google Scholar

Mantovani, G., Maccio, A., Esu, S., Lai, P., Santona, M.C., Massa, E., Dessi, D., Melis, G.B., and Del Giacco, G.S. (1997). Medroxyprogesterone acetate reduces the in vitro production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients. Eur. J. Cancer33, 602–607.10.1016/S0959-8049(96)00486-8Search in Google Scholar

Meruelo, D., Lavie, G., and Lavie, D. (1988). Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones hypericin and pseudohypericin. Proc. Natl. Acad. Sci. USA85, 5230–5234.10.1073/pnas.85.14.5230Search in Google Scholar

Müller, W.E., Singer, A., Wonnemann, M., Hafner, U., Rolli, M., and Schäfer, C. (1998). Hyperforin represents the neurotransmitter reuptake inhibiting constituent of Hypericum extract. Pharmacopsychiatry31, 16–21.10.1055/s-2007-979341Search in Google Scholar

Nathan, C.F., Murray, H.W., Wiebe, M.E., and Rubin, B.Y. (1983). Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med.158, 670–689.10.1084/jem.158.3.670Search in Google Scholar

Neurauter, G., Wirleitner, B., Schroecksnadel, K., Schennach, H., Ueberall, F., and Fuchs, D. (2003). PADMA 28 modulates interferon-γ-induced tryptophan degradation and neopterin production in human PBMC in vitro. Int. Immunopharmacol.4, 833–839.Search in Google Scholar

Ng, T.B., Liu, F., and Wang, Z.T. (2000). Antioxidative activity of natural products from plants. Life Sci.66, 709–723.10.1016/S0024-3205(99)00642-6Search in Google Scholar

Okuda, S., Nishiyama, N., Saito, H., and Katsuki, H. (1998). 3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity. J. Neurochem.70, 299–307.10.1046/j.1471-4159.1998.70010299.xSearch in Google Scholar PubMed

Schempp, C.M., Winghofer, B., Ludtke, R., Simon-Haarhaus, B., Schopf, E., and Simon, J.C. (2000). Topical application of St John's wort (Hypericum perforatum L.) and its metabolite hyperforin inhibits the allostimulatory capacity of epidermal cells. Br. J. Dermatol.142, 979–984.Search in Google Scholar

Weiss, G., Murr, C., Zoller, H., Haun, M., Widner, B., Ludescher, C., and Fuchs, D. (1999). Modulation of neopterin formation and tryptophan degradation by Th1- and Th2-derived cytokines in human monocytic cell. Clin. Exp. Immunol.116, 435–440.Search in Google Scholar

Widner, B., Werner, E.R., Schennach, H., Wachter, H., and Fuchs, D. (1997). Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin. Chem.43, 2424–2426.10.1093/clinchem/43.12.2424Search in Google Scholar

Widner, B., Laich, A., Sperner-Unterweger, B., Ledochowski, M., and Fuchs, D. (2002). Neopterin production, tryptophan degradation, and mental depression – what is the link?Brain Behav. Immun.16, 590–595.Search in Google Scholar

Winkler, C., Wirleitner, B., Schroecksnadel, K., Schennach, H., Mur, E., and Fuchs, D. (2004). In vitro effects of two extracts and two pure alkaloid preparations of Uncaria tomentosa on peripheral blood mononuclear cells. Planta Med.70, 205–210.Search in Google Scholar

Wirleitner, B., Neurauter, G., Schroecksnadel, K., Frick, B., and Fuchs, D. (2003a). Interferon-γ-induced conversion of tryptophan: immunologic and neuropsychiatric aspects. Curr. Med. Chem.10, 1581–1591.10.2174/0929867033457179Search in Google Scholar

Wirleitner, B., Rudzite, V., Neurauter, G., Murr, C., Kalnins, U., Erglis, A., Trusinskis, K., and Fuchs, D. (2003b). Immune activation and degradation of tryptophan in coronary heart disease. Eur. J. Clin. Invest.33, 550–554.10.1046/j.1365-2362.2003.01186.xSearch in Google Scholar

Woelk, H. (2000). Comparison of St. John's wort and imipramine for treating depression: randomised controlled trial. Br. Med. J.321, 536–539.Search in Google Scholar

Young, S.N., and Leyton, M. (2002). The role of serotonin in human mood and social interaction. Insight from altered tryptophan levels. Pharmacol. Biochem. Behav.71, 857–865.10.1016/S0091-3057(01)00670-0Search in Google Scholar

Zvetkova, E., Wirleitner, B., Tram, N.T., Schennach, H., and Fuchs, D. (2001). Aqueous extracts of Crinum latifolium (L.) and Camellia sinensis show immunomodulatory properties in human peripheral blood mononuclear cells. Int. Immunopharmacol.1, 2143–2150.Search in Google Scholar

Published Online: 2005-06-01
Published in Print: 2004-12-01

©2004 by Walter de Gruyter Berlin New York

Downloaded on 22.2.2026 from https://www.degruyterbrill.com/document/doi/10.1515/BC.2004.155/pdf
Scroll to top button